Metastasis-associated in colon cancer-1 associates with poor prognosis and promotes cell invasion and angiogenesis in human cervical cancer

International Journal of Gynecological Cancer

Volumn 25, Issue 8, 2015, Pages 1353-1363

  Zhou, Xiang ^a   Xu, Chang Juan ^b,c   Wang, Jun Xian ^a,b   Dai, Ting ^a   Ye, Ya Ping ^b   Cui, Yan Mei ^b   Liao, Wen Ting ^b   Wu, Xin Lin ^a   Ou, Jian Ping ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

Author keywords

Akt; Angiogenesis; Cervical cancer; Invasion; MACC1; NF B

Indexed keywords

GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; METASTASIS ASSOCIATED IN COLON CANCER 1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG; MACC1 PROTEIN, HUMAN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TUMOR MARKER;

AGGRESSIVENESS; ANGIOGENESIS; CANCER GROWTH; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; CERVICAL CANCER CELL LINE; CHORIOALLANTOIS; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MORPHOGENESIS; OVERALL SURVIVAL; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; UTERINE CERVIX CANCER; WESTERN BLOTTING; WOUND HEALING; ADENOCARCINOMA; CANCER GRADING; CELL MOTION; CELL PROLIFERATION; ENZYME IMMUNOASSAY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TUMOR CELL CULTURE; TUMOR INVASION; UTERINE CERVIX TUMOR; VASCULARIZATION;

ADENOCARCINOMA; BIOMARKERS, TUMOR; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; CELL PROLIFERATION; CHORIOALLANTOIC MEMBRANE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SURVIVAL RATE; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 84943153178     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0000000000000524     Document Type: Conference Paper

References (44)

1. Forouzanfar MH, Foreman KJ, Delossantos AM, Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet. 2011; 378: 1461-1484
2. Gien LT, Covens A,. Lymph node assessment in cervical cancer: prognostic and therapeutic implications. J Surg Oncol. 2009; 99: 242-247
3. Ota T, Suzuki Y, Nishikawa T, Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004; 36: 40-45
4. Stein U, Walther W, Arlt F, MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med. 2009; 15: 59-67
5. Kokoszynska K, Krynski J, Rychlewski L, Unexpected domain composition of MACC1 links MET signaling and apoptosis. Acta Biochim Pol. 2009; 56: 317-323
6. Xie C, Wu J, Yun J, MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma. PLoS One. 2013; 8: e64235
7. Meng F, Li H, Shi H, MACC1 down-regulation inhibits proliferation and tumourigenicity of nasopharyngeal carcinoma cells through Akt/beta-catenin signaling pathway. PLoS One. 2013; 8: e60821
8. Chundong G, Uramoto H, Onitsuka T, Molecular diagnosis of MACC1 status in lung adenocarcinoma by immunohistochemical analysis. Anticancer Res. 2011; 31: 1141-1145
9. Guo T, Yang J, Yao J, Expression of MACC1 and c-Met in human gastric cancer and its clinical significance. Cancer Cell Int. 2013; 13: 121
10. Wang Z, Li Z, Wu C, MACC1 overexpression predicts a poor prognosis for non-small cell lung cancer. Med Oncol. 2014; 31: 790
11. Wang G, Kang MX, Lu WJ, MACC1: a potential molecule associated with pancreatic cancer metastasis and chemoresistance. Oncol Lett. 2012; 4: 783-791
12. Guo L, Lu W, Zhang X, Metastasis-Associated colon cancer-1 is a novel prognostic marker for cervical cancer. Int J Clin Exp Pathol. 2014; 7: 4150-4155
13. Zhang R, Shi H, Chen Z, Effects of metastasis-Associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells. J Exp Clin Cancer Res. 2011; 30: 83
14. Zhang SH, Wang CJ, Shi L, High expression of FLOT1 is associated with progression and poor prognosis in hepatocellular carcinoma. PLoS One. 2013; 8: e64709
15. Song LB, Li J, Liao WT, The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest. 2009; 119: 3626-3636
16. Huang Y, Zhang H, Cai J, Overexpression of MACC1 and its significance in human breast cancer progression. Cell Biosci. 2013; 3: 16
17. Kawamura M, Saigusa S, Toiyama Y, Correlation of MACC1 and MET expression in rectal cancer after neoadjuvant chemoradiotherapy. Anticancer Res. 2012; 32: 1527-1531
18. Qiu J, Huang P, Liu Q, Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma. J Transl Med. 2011; 9: 166
19. Wang L, Wu Y, Lin L, Metastasis-Associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion. Int J Cancer. 2013; 133: 1419-1430
20. Stein U, Burock S, Herrmann P, Circulating MACC1 transcripts in colorectal cancer patient plasma predict metastasis and prognosis. PLoS One. 2012; 7: e49249
21. Ren B, Zakharov V, Yang Q, MACC1 is related to colorectal cancer initiation and early-stage invasive growth. Am J Clin Pathol. 2013; 140: 701-707
22. Lin L, Huang H, Liao W, MACC1 supports human gastric cancer growth under metabolic stress by enhancing the Warburg effect. Oncogene. 2015; 34: 2700-2710
23. Gao J, Ding F, Liu Q, Knockdown of MACC1 expression suppressed hepatocellular carcinoma cell migration and invasion and inhibited expression of MMP2 and MMP9. Mol Cell Biochem. 2013; 376: 21-32
24. Birchmeier C, Birchmeier W, Gherardi E, Met, metastasis, motility and more. Nat Rev Mol Cell Biol. 2003; 4: 915-925
25. Sattler M, Salgia R,. c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy. Curr Oncol Rep. 2007; 9: 102-108
26. Mazzone M, Comoglio PM,. The Met pathway: master switch and drug target in cancer progression. FASEB J. 2006; 20: 1611-1621
27. Phoophitphong T, Hanprasertpong J, Dechsukhum C, Correlation of angiogenesis and recurrence-free survival of early stage cervical cancer patients undergoing radical hysterectomy with pelvic lymph node dissection. J Obstet Gynaecol Res. 2007; 33: 840-848
28. Albini A, Tosetti F, Li VW, Cancer prevention by targeting angiogenesis. Nat Rev Clin Oncol. 2012; 9: 498-509
29. Chien MH, Ku CC, Johansson G, Vascular endothelial growth factor-C (VEGF-C) promotes angiogenesis by induction of COX-2 in leukemic cells via the VEGF-R3/JNK/AP-1 pathway. Carcinogenesis. 2009; 30: 2005-2013
30. Roomi MW, Monterrey JC, Kalinovsky T, In vitro modulation of MMP-2 and MMP-9 in human cervical and ovarian cancer cell lines by cytokines, inducers and inhibitors. Oncol Rep. 2010; 23: 605-614
31. John A, Tuszynski G,. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res. 2001; 7: 14-23
32. Branca M, Ciotti M, Giorgi C, Matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor (TIMP-2) are prognostic factors in cervical cancer, related to invasive disease but not to high-risk human papillomavirus (HPV) or virus persistence after treatment of CIN. Anticancer Res. 2006; 26: 1543-1556
33. Li Y, Wu T, Zhang B, Matrix metalloproteinase-9 is a prognostic marker for patients with cervical cancer. Med Oncol. 2012; 29: 3394-3399
34. Sheu BC, Lien HC, Ho HN, Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer. Cancer Res. 2003; 63: 6537-6542
35. Wu Y, Zhou BP,. TNF-Alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion. Br J Cancer. 2010; 102: 639-644
36. Bodelon C, Madeleine MM, Johnson LG, Genetic variation in the TLR and NF-kappaB pathways and cervical and vulvar cancer risk: a population-based case-control study. Int J Cancer. 2014; 134: 437-444
37. Shehata MF,. Rel/Nuclear factor-kappa B apoptosis pathways in human cervical cancer cells. Cancer Cell Int. 2005; 5: 10
38. Li J, Jia H, Xie L, Association of constitutive nuclear factor-kappaB activation with aggressive aspects and poor prognosis in cervical cancer. Int J Gynecol Cancer. 2009; 19: 1421-1426
39. Nair A, Venkatraman M, Maliekal TT, NF-kappaB is constitutively activated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix. Oncogene. 2003; 22: 50-58
40. Rauvala M, Aglund K, Puistola U, Matrix metalloproteinases-2 and-9 in cervical cancer: different roles in tumor progression. Int J Gynecol Cancer. 2006; 16: 1297-1302
41. Basseres DS, Baldwin AS,. Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene. 2006; 25: 6817-6830
42. Baldwin AS,. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest. 2001; 107: 241-246
43. Cheng JC, Chou CH, Kuo ML, Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway. Oncogene. 2006; 25: 7009-7018
44. Lee SJ, Bae SS, Kim KH, High glucose enhances MMP-2 production in adventitial fibroblasts via Akt1-dependent NF-kappaB pathway. FEBS Lett. 2007; 581: 4189-4194